Wendell David Associates Inc Idexx Laboratories Inc Transaction History

Wendell David Associates Inc

  • $1.05 Billion
  • Q3 2024

A detailed history of Wendell David Associates Inc transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Wendell David Associates Inc holds 17,252 shares of IDXX stock, worth $7.22 Million. This represents 0.83% of its overall portfolio holdings.

Number of Shares
17,252
Previous 18,749 7.98%
Holding current value
$7.22 Million
Previous $9.14 Million 4.59%
% of portfolio
0.83%
Previous 0.93%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024
SELL
$455.08 - $517.19 $681,254 - $774,233
-1,497 Reduced 7.98%
17,252 $8.72 Million
Q2 2024

Jul 22, 2024
BUY
$468.04 - $548.53 $32,762 - $38,397
70 Added 0.37%
18,749 $9.14 Million
Q1 2024

Apr 22, 2024
SELL
$515.08 - $576.87 $203,456 - $227,863
-395 Reduced 2.07%
18,679 $10.1 Million
Q4 2023

Jan 22, 2024
SELL
$391.37 - $557.56 $28,178 - $40,144
-72 Reduced 0.38%
19,074 $10.6 Million
Q3 2023

Oct 20, 2023
BUY
$432.42 - $556.67 $192,426 - $247,718
445 Added 2.38%
19,146 $8.37 Million
Q2 2023

Jul 20, 2023
SELL
$450.7 - $503.61 $92,393 - $103,240
-205 Reduced 1.08%
18,701 $9.39 Million
Q1 2023

Apr 19, 2023
SELL
$406.01 - $514.59 $23,142 - $29,331
-57 Reduced 0.3%
18,906 $9.46 Million
Q4 2022

Jan 17, 2023
SELL
$324.64 - $441.27 $129,206 - $175,625
-398 Reduced 2.06%
18,963 $7.74 Million
Q3 2022

Oct 18, 2022
SELL
$325.8 - $407.78 $223,173 - $279,329
-685 Reduced 3.42%
19,361 $6.31 Million
Q2 2022

Jul 14, 2022
SELL
$327.37 - $553.44 $233,414 - $394,602
-713 Reduced 3.43%
20,046 $7.03 Million
Q1 2022

Apr 22, 2022
SELL
$466.52 - $631.01 $480,515 - $649,940
-1,030 Reduced 4.73%
20,759 $11.4 Million
Q4 2021

Jan 24, 2022
SELL
$586.54 - $666.48 $547,241 - $621,825
-933 Reduced 4.11%
21,789 $14.3 Million
Q3 2021

Oct 19, 2021
SELL
$621.9 - $705.76 $724,513 - $822,210
-1,165 Reduced 4.88%
22,722 $14.1 Million
Q2 2021

Jul 19, 2021
SELL
$486.36 - $637.08 $294,247 - $385,433
-605 Reduced 2.47%
23,887 $15.1 Million
Q1 2021

Apr 20, 2021
SELL
$465.18 - $551.79 $339,581 - $402,806
-730 Reduced 2.89%
24,492 $12 Million
Q4 2020

Jan 22, 2021
SELL
$383.85 - $499.87 $69,093 - $89,976
-180 Reduced 0.71%
25,222 $12.6 Million
Q3 2020

Oct 20, 2020
SELL
$334.54 - $406.31 $46,835 - $56,883
-140 Reduced 0.55%
25,402 $9.99 Million
Q2 2020

Jul 17, 2020
SELL
$230.66 - $330.16 $259,492 - $371,430
-1,125 Reduced 4.22%
25,542 $8.43 Million
Q1 2020

Apr 16, 2020
SELL
$182.94 - $290.97 $49,393 - $78,561
-270 Reduced 1.0%
26,667 $6.46 Million
Q4 2019

Jan 17, 2020
BUY
$248.66 - $285.01 $1,740 - $1,995
7 Added 0.03%
26,937 $7.03 Million
Q3 2019

Oct 22, 2019
SELL
$260.07 - $289.93 $221,059 - $246,440
-850 Reduced 3.06%
26,930 $7.32 Million
Q2 2019

Jul 16, 2019
SELL
$215.53 - $275.33 $59,270 - $75,715
-275 Reduced 0.98%
27,780 $7.65 Million
Q1 2019

Apr 11, 2019
SELL
$178.02 - $225.69 $237,656 - $301,296
-1,335 Reduced 4.54%
28,055 $6.27 Million
Q4 2018

Jan 17, 2019
SELL
$176.18 - $248.92 $172,832 - $244,190
-981 Reduced 3.23%
29,390 $5.47 Million
Q3 2018

Oct 12, 2018
SELL
$218.82 - $254.46 $180,964 - $210,438
-827 Reduced 2.65%
30,371 $7.58 Million
Q2 2018

Jul 16, 2018
BUY
$185.56 - $227.9 $213,394 - $262,085
1,150 Added 3.83%
31,198 $6.8 Million
Q1 2018

Apr 11, 2018
SELL
$157.81 - $204.73 $854,225 - $1.11 Million
-5,413 Reduced 15.26%
30,048 $5.75 Million
Q4 2017

Jan 16, 2018
SELL
$147.68 - $168.37 $78,418 - $89,404
-531 Reduced 1.48%
35,461 $5.55 Million
Q3 2017

Oct 17, 2017
BUY
$150.32 - $166.46 $5.41 Million - $5.99 Million
35,992
35,992 $5.6 Million

Others Institutions Holding IDXX

# of Institutions
1,210
Shares Held
73.3M
Call Options Held
167K
Put Options Held
343K
View Full List

About IDEXX LABORATORIES INC

IDXX Quotes by TradingView
  • Ticker IDXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 83,253,696
  • Market Cap $34.8B
  • Description
  • IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...
More about IDXX
Track This Portfolio

Track Wendell David Associates Inc Portfolio

Follow Wendell David Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wendell David Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wendell David Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email